Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Lionel Leventhal is a finance expert, entrepreneur, and philanthropist based in the United States. He specializes in providing non-dilutive revenue financing solutions to pharmaceutical, biotech, medical device, and diagnostic companies. He is also a board member at ART MEDICAL Ltd., an Israeli medical device company. Leventhal has an extensive background in investment banking, commercial and residential property development, and management consulting. He is an alumnus of Harvard Business School and Harvard University.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Lionel Leventhal's primary investment focus by sector?
- Lionel Leventhal primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.
- Can you name a notable exit for Lionel Leventhal?
- A notable exit for Lionel Leventhal is Pulsenmore, which went public on the TASE in June 2021 with a valuation of $190M, having raised $40M in capital prior to the event.
- What is a key portfolio company for Lionel Leventhal?
- A key portfolio company for Lionel Leventhal is Pulsenmore, a company founded in 2014 that develops handheld ultrasound devices and has raised $110.8M.
- When did Lionel Leventhal make their most recent recorded investment?
- Lionel Leventhal's most recent recorded investment occurred in May 2019.
- What is the typical investment range for Lionel Leventhal?
- Lionel Leventhal's investment range is between $3.25M and $3.25M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1999 |
|---|